Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer
- 1 February 2006
- Vol. 67 (2) , 349-353
- https://doi.org/10.1016/j.urology.2005.08.047
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Impact of the Percentage of Positive Prostate Cores on Prostate Cancer–Specific Mortality for Patients With Low or Favorable Intermediate-Risk DiseaseJournal of Clinical Oncology, 2004
- The Changing Face of Low-Risk Prostate Cancer: Trends in Clinical Presentation and Primary ManagementJournal of Clinical Oncology, 2004
- Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomyCancer, 2003
- Preoperative p27 Status is an Independent Predictor of Prostate Specific Antigen Failure Following Radical ProstatectomyJournal of Urology, 2003
- Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomesSeminars in Radiation Oncology, 2002
- Biopsy Results after Real-Time Ultrasound-Guided Transperineal Implants for Stage T1-T2 Prostate CancerJournal of Endourology, 2000
- The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S.Cancer, 1999
- Systematic 5 Region Prostate Biopsy is Superior to Sextant Method for Diagnosing Carcinoma of the ProstateJournal of Urology, 1997
- DOES BRACHYTHERAPY HAVE A ROLE IN THE TREATMENT OF PROSTATE CANCER?Hematology/Oncology Clinics of North America, 1996